MB "ANG Pharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 1,549 |
| - |
| -5,908 |
| -5,908 |
| - |
| 63.65 |
| -381.41 |
| -5,908 |
| 19,501 |
| 0 |
| 13,593 |
| 2023 |
|---|
| 38,045 |
| - |
| 7,853 |
| 7,693 |
| - |
| 63.90 |
| 20.22 |
| 1,785 |
| 25,906 |
| 0 |
| 27,691 |
| 2024 |
|---|
| 31,602 |
| - |
| 5,382 |
| 5,147 |
| - |
| 65.19 |
| 16.29 |
| 6,932 |
| 13,921 |
| 0 |
| 20,853 |
Register and
explore Okredo data| 2024 |
|---|
| 31,602 |
| - |
| 5,382 |
| 5,147 |
| - |
| 65.19 |
| 16.29 |
| 6,932 |
| 13,921 |
| 0 |
| 20,853 |
Register and
explore Okredo data2024
Turnover (€)
31,602 €
-17 % *
Sales per employee (€)
-Profit before tax (€)
5,382 €-31 % *
Net Profit (€)
5,147 €-33 % *
Profit per employee (€)
-Total profitability (%)
65.19 %
2.02 % *
Net profitability (%)
16.29 %-19.44 % *
Equity (€)
6,932 €288 % *
Amounts Payable And Liabilities (€)
13,921 €
-46 % *
Non-current Assets (€)
0 €
- *
CurrentAssets (€)
20,853 €-25 % *